Clover Health Investments (CLOV) Shares Outstanding (2019 - 2026)

Clover Health Investments (CLOV) has 8 years of Shares Outstanding data on file, last reported at $429.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 3.72% year-over-year to $429.6 million; the trailing twelve-month figure through Mar 2026 stood at $429.6 million (up 3.72% YoY), and the FY2025 full-year result was $92.4 million, down 77.71% from the prior year.
• Shares Outstanding for Q1 2026 stood at $429.6 million, up from $92.4 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $429.6 million in Q1 2026 and bottomed at $1.9 million in Q1 2022.
• The 5-year median for Shares Outstanding is $401.2 million (2023), against an average of $345.1 million.
• The widest annual swing landed in 2023, when Shares Outstanding slumped 81.3%; it then soared 368.04% in 2024.
• A 5-year view of Shares Outstanding shows it stood at $384.0 million in 2022, then grew by 4.48% to $401.2 million in 2023, then rose by 3.32% to $414.5 million in 2024, then plunged by 77.71% to $92.4 million in 2025, then jumped by 365.02% to $429.6 million in 2026.
• The last three Shares Outstanding figures came in at $429.6 million (Q1 2026), $92.4 million (Q4 2025), and $421.8 million (Q3 2025), per Business Quant data.

Peer Comparison